Ctor (TNF) signaling pathway, Fc gamma Rmediated phagocytosis, and T cell
Ctor (TNF) signaling pathway, Fc gamma Rmediated phagocytosis, and T cell receptor signaling pathway (Table 5). Immune program has been around the stage for fairly some time in many processes from neurogenesis to brain tumors and neurodegeneration [58, 59]. TNF, as an example, was shown to inhibit neurite outgrowth within the hippocampus [60]. In addition, presence of active T cells have been identified to become crucial forPLOS A single DOI:0.37journal.pone.070585 February three, Novel transcriptional targets of PeaTable five. PANOGA evaluation of microarray results. Data was run 5 occasions, and genes with statistical significance had been reported for occurrence and name. Pathways of interest are indicated in bold. Pathways Cell cycle MAPK signaling pathway pvalue four,8748E2 7,39475E9 ,864E7 4,6808E4 4,2358E3 six,05774E3 3,5804E2 3,82705E2 6,46398E2 ,08568E ,349E 3,0438E 5,5292E ,09676E0 ,2339E0 ,58743E0 ,69056E0 ,88693E0 2,43063E0 two,6459E0 3,38556E0 Occurrence Impacted Genes five 5 RB, PKMYT, FZR, CCND, YWHAQ, E2F, CDC25A MAX, ARRB, ARRB2, DUSP6, ELK, RELA, RELB, RPS6KA4, RPS6KA3, MAPK, RAC3, CACNG2, DUSP4, MAP3K3, JUND, TRAF2, DUSP7, TAOK2, MAP3K, FGFR RB, RET, MedChemExpress K162 PIK3R2, RELA, RXRB, CCND, GNA, DVL2, E2F, MAPK, RAC3, FADD, PLCG, VHL, RALGDS, APC2, JUP, DAPK3, ARNT, AXIN2, RARA, ARHGEF, FGFR RET, AP2A, AP2A2, GIT, SH3GL, AP2B, VPS37B, SMAD6, DNM, EPN, DNM2, EPN2, RABB, SMAD7, CHMP4B MAP3K3, NGFR, SHC, PIK3R2, RELA, RPS6KA3, ARHGDIA, RAPGEF, BAX, MAPK, PLCG LAMA5, SHC, PIK3R2, ELK, CCND, MAPK, VASP, GRLF, VAV2, COL6A, ITGA, RAPGEF SDC4, PIK3R2, ELK, CCND, GPC, MAPK, PLCG, VAV2, RPS6KB2, ARHGEF, PTPN6, FGFR AGPAT, AGPAT2, AGPAT4 VAMP2 PIK3R2, TRAF2, RELA, RPS6KA4, CREB3L3, MAPK, JUNB RB, SHC, PIK3R2, RELA, CCND, E2F, MAPK VASP, SPHK2, PIK3R2, DNM2, VAV2, MAPK, PIP5KA, PLCG, WASF2 RB, PIK3R2, ELK, RELA, CCND, YWHAQ, E2F, BAX, MAPK, PTK2B, FADD APC2, PIK3R2, AXIN2, CCND, BAX, CYCS, MAPK, RAC3, RALGDS DFFA, PIK3R2, TRAF2, RELA, PRKAR2A, BAX, CYCS, CAPN, FADD MAP3K3, ELK, PLCB3, GNA, MAPK, PTK2B PIK3R2, RELA, VAV2, MAPK, PTPN6, PLCG, NFKBIB MAPK, RAC3, PTPN6, WASF2, FGFR AGPAT, AGPAT2 AP2A, CPLX2, DNM, VAMP2 PIK3R2, RELA, RELB, YWHAQ, POLR3H, TAB MAX, MLLT, RELA, CCND2, RXRG, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/22479345 NGFR, TAF5, JUP, FUS, TFE3, ETV4, RARA, TCF3 INPPL, PIK3R2, RELA, VAV2, CD79A, MAPK, PTPN6, NFKBIB LAMA5, COL6A2, COL6A, ITGA SHC, PIK3R2, ELK, RELA, SYNGAP, MAPK, PLCG, RALGDS, NGFR, EFNA3, RASA3, GNB, EPHA2 SHC, PIK3R2, ELK, RPS6KB2, MAPK, PLCG (Continued)Pathways in cancerEndocytosis Neurotrophin signaling pathway Focal adhesion 
Proteoglycans in cancer Glycerolipid metabolism SNARE interactions in vesicular transport TNF signaling pathway Chronic myeloid leukemia Fc gamma Rmediated phagocytosis Hepatitis B Colorectal cancer Apoptosis GnRH signaling pathway T cell receptor signaling pathway Adherens junction Fat digestion and absorption Synaptic vesicle cycle EpsteinBarr virus infection5 5 four 5 3 two five 5 5 five four 3 five five 3 five 3 five 2 4Transcriptional misregulation in cancer four,4283E0 B cell receptor signaling pathway ECMreceptor interaction Ras signaling pathway ErbB signaling pathway 6,64022E0 6,76663E0 7,02702E0 ,05542EPLOS 1 DOI:0.37journal.pone.070585 February three,2 Novel transcriptional targets of PeaTable five. (Continued) Pathways Basal transcription aspects Bladder cancer Prostate cancer Nonsmall cell lung cancer Rap signaling pathway Viral carcinogenesis Regulation of actin cytoskeleton Smaller cell lung cancer Chemokine signaling pathway Acute myeloid leukemia Pancreatic cancer Osteoclast differentiation Progesteronemedia.